BlinkLab Limited (ASX:BB1)

Market Cap	98.84M +134.0%
Revenue (ttm)	375.82K +92.9%
Net Income	-7.24M
EPS	-0.07
Shares Out	125.91M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	130,182
Average Volume	178,950
Open	0.8500
Previous Close	0.8100
Day's Range	0.7850 - 0.8500
52-Week Range	0.3100 - 1.1050
Beta	1.71
RSI	46.28
Earnings Date	May 25, 2026

About BlinkLab

BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations. The company’s application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Perth, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2021
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: BB1

Financial Performance

In fiscal year 2025, BlinkLab's revenue was 375,551, an increase of 916.07% compared to the previous year's 36,961. Losses were -5.71 million, 225.5% more than in 2024.